Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.21.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation

11. Stock-Based Compensation

 

Equity Incentive Plans – The Company’s 2013 Equity Compensation Plan (the “2013 Plan”) was adopted for the purpose of providing equity incentives to employees, officers, directors and consultants including options, restricted stock, restricted stock units, stock appreciation rights, other equity awards, annual incentive awards and dividend equivalents. Through a series of amendments to the 2013 Plan, the number of authorized shares available for issuance of common stock under the Plan increased from 225,000 shares to 915,000 shares. The Company further amended the 2013 Plan to increase the number of authorized shares of common stock under the Plan by 585,000 shares, which the Company’s stockholders approved and ratified on June 14, 2021. The Company is now authorized to issue 1,500,000 shares under the amended 2013 Plan.

 

Stock Options

 

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

 

Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

 

The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2021 and 2020:

 

                Weighted        
                Average        
          Weighted     Remaining        
          Average     Contractual     Aggregate  
    Number of     Exercise     Life     Intrinsic  
    Options     Price     (in Years)     Value  
Outstanding - January 1, 2021     66,126     $ 5.24       8.3     $      -  
Granted     30,000       2.10       9.7          
Exercised     -       -       -          
Forfeited     (30,000 )     3.69       -          
Outstanding - September 30 2021     66,126     $ 4.52       8.6     $ -  
                                 
Exercisable at September 30, 2021     36,126     $ 6.53       6.6     $ -  

 

                Weighted        
                Average        
          Weighted     Remaining        
          Average     Contractual     Aggregate  
    Number of     Exercise     Life     Intrinsic  
    Options     Price     (in Years)     Value  
Outstanding - January 1, 2020     295,793     $ 8.88              7.5     $      -  
Granted     30,000       3.69       9.7          
Exercised     -       -       -          
Forfeited     (259,667 )     9.21       -          
Outstanding - September 30, 2020     66,126     $ 5.24       8.6     $ -  
                                 
Exercisable at September 30, 2020     26,126     $ 8.18       4.2     $ -  

 

Total unrecognized pre-tax stock-based compensation expense related to unvested stock options at September 30, 2021 was approximately $0.

 

Warrants

 

As of September 30, 2021 and December 31, 2020, 125,000 warrants were outstanding and exercisable with an exercise price of $20.00 per share. The aggregate intrinsic value was $0 and the warrants are scheduled to expire on December 30, 2021.

 

 

Restricted Stock

 

As of September 30, 2021 and 2020, the following is a summary of restricted stock activity:

    Number of  
    Shares  
Outstanding - January 1, 2021     233,875  
Granted     59,524  
Forfeited     -  
Vested     (133,875 )
Outstanding - September 30, 2021     159,524  

 

    Number of  
    Shares  
Outstanding - January 1, 2020     27,319  
Granted     306,775  
Forfeited     -  
Vested     (127,319 )
Outstanding - September 30, 2020     206,775  

 

Additionally, the Company had no non-cash pre-tax stock-based compensation expense recorded for the nine months ended September 30, 2021 and 2020, respectively, as a component of general and administrative expenses in the accompanying statements of operations, pertaining to restricted stock.

 

Total unrecognized pre-tax stock-based compensation expense related to unvested restricted stock at September 30, 2021 was $0.